Scientists at Nanyang Technological University,
Singapore (NTU Singapore) have developed insulin nanoparticles that
may one day become the basis for an oral medicine, and an
alternative to insulin injections for diabetic
patients.
Researchers develop oral insulin nanoparticles that could be
an alternative to jabs

